David T. Felson, MD, MPH
Professor
Boston University School of Medicine
Dept of Medicine
Rheumatology

MD, Johns Hopkins University
MPH, Boston University School of Public Health




Dr. David Felson's research interests include: understanding how to prevent osteoarthritis and treat osteoarthritis. In osteoarthritis, Dr. Felson’s interests include studying whether treatments for rheumatic diseases are effective and particularly in osteoarthritis, identifying biomechanical risk factors for disease and testing biomechanical treatments and characterizing MRI features of normal knees and knees with pain. He also studies outcome measurement in rheumatic disease and has focused in this work on rheumatoid arthritis trials.

Professor
Boston University School of Public Health
Epidemiology


Investigator
Framingham Heart Study


Member
Boston University
Arthritis & Autoimmune Diseases Research Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences




Institutional Career Development
04/15/2020 - 03/31/2025 (PI)
NIH/National Center for Advancing Translational Sciences
5KL2TR001411-06

Boston University CCCR
09/11/2019 - 07/31/2024 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5P30AR072571-03

FastOA-MIL: Identification of Rapid Progression of PTOA in the Military Health System
10/29/2021 - 10/28/2023 (PI)
Arthritis Foundation


Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis
07/01/2020 - 06/30/2023 (Subcontract PI)
Hebrew SeniorLife NIH NIAMS
5R01AR075356-02

Fats, Fiber and Osteoarthritis
08/01/2017 - 05/31/2023 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5R01AR071950-04

Uncovering the Genetic Mechanisms Behind Joint-Specific Osteoarthritis
04/01/2018 - 01/31/2023 (Subcontract PI)
President and Fellows of Harvard College NIH NIAMS
5R01AR070139-05

Multicenter Osteoarthritis Study (MOST) Second Renewal-Boston University
07/01/2015 - 05/31/2022 (PI)
NIH/National Institute on Aging
5U01AG018820-18

FastOA: Predictors of rapid symptom progression after ACL reconstruction
01/01/2021 - 12/31/2021 (Subcontract PI)
Cleveland Clinic Foundation Arthritis Foundation


Rheumatology Training Grant
05/01/2014 - 09/16/2020 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5T32AR007598-20

The Boston University Clinical and Transitional Science Institute (KL-2 Award, PI Felson)
04/01/2018 - 03/31/2020 (PI)
NIH/National Center for Advancing Translational Sciences
5KL2TR001411-04

Showing 10 of 48 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2022 Administrative Core 5P30AR072571-04-7274
2022 Boston University CCCR 5P30AR072571-04
2021 Boston University CCCR 5P30AR072571-03
2021 Administrative Core 5P30AR072571-03-7274
2021 Institutional Career Development 5KL2TR001411-06 22
2020 Administrative Core 5P30AR072571-02-7274
2020 Boston University CCCR 5P30AR072571-02
2020 Fats, Fiber and Osteoarthritis 5R01AR071950-04 1
2020 Institutional Career Development 2KL2TR001411-05A1 22
2019 Administrative Core 1P30AR072571-01A1-7274
Showing 10 of 161 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Zertuche JP, Rabasa G, Lichtenstein AH, Matthan NR, Nevitt M, Torner J, Lewis CE, Dai Z, Misra D, Felson D. Alkylresorcinol, a biomarker for whole grain intake, and its association with osteoarthritis: the MOST study. Osteoarthritis Cartilage. 2022 Oct; 30(10):1337-1343.View Related Profiles. PMID: 35863678
     
  2. Kim JS, Borges S, Clauw DJ, Conaghan PG, Felson DT, Fleming TR, Glaser R, Hart E, Hochberg M, Kim Y, Kraus VB, Lapteva L, Li X, Majumdar S, McAlindon TE, Mobasheri A, Neogi T, Roemer FW, Rothwell R, Shibuya R, Siegel J, Simon LS, Spindler KP, Nikolov NP. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit. Semin Arthritis Rheum. 2022 Oct; 56:152070.View Related Profiles. PMID: 35870222
     
  3. Jafarzadeh SR, Neogi T, White DK, Felson DT. The Relationship of Pain Reduction With Prevention of Knee Replacement Under Dynamic Intervention Strategies. Arthritis Rheumatol. 2022 Jun 20.View Related Profiles. PMID: 35726122; DOI: 10.1002/art.42272;
     
  4. Carlesso LC, Jafarzadeh SR, Stokes A, Felson DT, Wang N, Frey-Law L, Lewis CE, Nevitt M, Neogi T. Depressive symptoms and multi-joint pain partially mediate the relationship between obesity and opioid use in people with knee osteoarthritis. Osteoarthritis Cartilage. 2022 Sep; 30(9):1263-1269.View Related Profiles. PMID: 35700904; DOI: 10.1016/j.joca.2022.06.002;
     
  5. Felson D, Feathers V, Naik C, Solomon DH, Weinblatt ME, Shadick N. Meaning of patient global assessment when joint counts are low in rheumatoid arthritis. RMD Open. 2022 Jun; 8(2). PMID: 35738804; PMCID: PMC9226990; DOI: 10.1136/rmdopen-2022-002346;
     
  6. Liu M, Huang Y, Zhang H, Aitken D, Nevitt MC, Rockel JS, Pelletier JP, Lewis CE, Torner J, Rampersaud YR, Perruccio AV, Mahomed NN, Furey A, Randell EW, Rahman P, Sun G, Martel-Pelletier J, Kapoor M, Jones G, Felson D, Qi D, Zhai G. Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents Obesity. Metabolites. 2022 Apr 07; 12(4). PMID: 35448521; PMCID: PMC9030079; DOI: 10.3390/metabo12040334;
     
  7. Murphy MT, Wang N, Felson DT, Nevitt MC, Lewis CE, Frey-Law L, Guermazi A, Segal NA. Association between hamstring coactivation during isokinetic quadriceps strength testing and knee cartilage worsening over 24 months. Osteoarthritis Cartilage. 2022 Jun; 30(6):823-831.View Related Profiles. PMID: 35307535
     
  8. Gates LS, Perry TA, Golightly YM, Nelson AE, Callahan LF, Felson D, Nevitt M, Jones G, Cooper C, Batt ME, Sanchez-Santos MT, Arden NK. Recreational Physical Activity and Risk of Incident Knee Osteoarthritis: An International Meta-Analysis of Individual Participant-Level Data. Arthritis Rheumatol. 2022 04; 74(4):612-622. PMID: 34730279
     
  9. Liew JW, Peloquin C, Tedeschi SK, Felson DT, Zhang Y, Choi HK, Terkeltaub R, Neogi T. Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study. Arthritis Care Res (Hoboken). 2022 Mar 04.View Related Profiles. PMID: 35245410; PMCID: PMC9440954; DOI: 10.1002/acr.24876;
     
  10. Roemer FW, Felson DT, Stefanik JJ, Rabasa G, Wang N, Crema MD, Neogi T, Nevitt MC, Torner J, Lewis CE, Peloquin C, Guermazi A. Heterogeneity of cartilage damage in Kellgren and Lawrence grade 2 and 3 knees: the MOST study. Osteoarthritis Cartilage. 2022 May; 30(5):714-723.View Related Profiles. PMID: 35202808; PMCID: PMC9433455; DOI: 10.1016/j.joca.2022.02.614;
     
Showing 10 of 969 results. Show More